- Global Pharma News & Resources

Press Releases - 2023-03-09

Date Title Company
09-Mar-2023 Lateral Flow Assays Market is projected to reach a valuation of US$ 6.9 billion by 2033 | FMI MARKITWIRED
09-Mar-2023 Areteia Therapeutics meldet Start der klinischen Phase-III-Studien zu oral verabreichtem Dexpramipexol bei eosinophilem Asthma Businesswire
09-Mar-2023 Invitation to MorphoSys’ Full Year Results 2022 Conference Call on March 16, 2023 MorphoSys AG
09-Mar-2023 Neurostimulation Market to Propel at Impressive CAGR of 11.5% from 2022 to 2032 as it Improves the Quality of Life of Patients Globally MARKITWIRED
09-Mar-2023 Transgene Appoints John C. Bell and Pedro Romero as Key Scientific Advisors Businesswire
09-Mar-2023 Prolific Class-Action Law Firm Hagens Berman Celebrates 30 Years of Fighting for Clients and Causes Businesswire
09-Mar-2023 Areteia Therapeutics annonce le début d'essais cliniques de Phase III pour le dexpramipexole oral dans le traitement de l’asthme éosinophilique Businesswire
09-Mar-2023 Paige and Mindpeak Launch an Integrated Solution for Enhanced Cancer Diagnosis Businesswire
09-Mar-2023 InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury Businesswire
09-Mar-2023 Crown Bioscience Opens Singapore Laboratory and Establishes Local Commercial Partner Businesswire
09-Mar-2023 New Alliance of Health Care Leaders Calls on Congress to Save America’s 340B Program Businesswire
09-Mar-2023 Lixoft Adds New Data Formatting and Reporting Modules to MonolixSuite™ in Version 2023R1 Businesswire
09-Mar-2023 Charles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing Businesswire
09-Mar-2023 Bigfoot Biomedical Named to Fast Company’s “World’s Most Innovative Companies” List Businesswire
09-Mar-2023 Ribon Therapeutics Doses First Patient in Phase 1 Clinical Study with RBN-3143 in Patients with Moderate-to-Severe Atopic Dermatitis Businesswire
09-Mar-2023 Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S. Businesswire
09-Mar-2023 Vertex Announces FDA Clearance of Investigational New Drug Application for VX-264, a Novel Encapsulated Cell Therapy for the Treatment of Type 1 Diabetes Businesswire
09-Mar-2023 REVEAL GENOMICS®´ Breakthrough Technology Enters the Liquid Biopsy Field in Oncology Businesswire
09-Mar-2023 OmniAb to Report Fourth Quarter 2022 Financial Results on March 30 Businesswire